No. 11 / 2026Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results